Ege University Medical Faculty

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Haemophilia1 trial
• Lung cancer1 trial
• Melanoma1 trial

Phase

• Phase 33 trials

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• CSL Behring1 trial
• Pfizer1 trial
• Takeda1 trial

Running trials

• Recruiting

  Efficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)

  NCT06003387· Phase 3· CSL Behring· Source

  Contact: Trial Registration Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Haemophilia1 recruiting

Closed trials

• Completed

  TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations

  NCT04129502· Phase 3· Takeda· Source

• Completed

  Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma

  NCT01909453· Phase 3· Pfizer· Source